This announcement is a separate document:
亨迪药业:国泰君安证券股份有限公司关于湖北亨迪药业股份有限公司2024年半年度持续督导跟踪报告
Hengdi Pharmaceutical: Guotai Junan Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Hubei Hengdi Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.